Journals / Solunum / 2014 / Cilt: 16 - Sayı: 1

Bronchial Anthracosis - Anthracofibrosis: Potential Causes and Clinical Characteristics

Journal
Solunum
Pages
17–20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Such patients should be evaluated and followed-up for various pulmonary diseases including COPD, pneumonia, tuberculosis and malignancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Anthracosis is characterized by accumulation of black pigment in the bronchial mucosa.
📊
Key Findings & Data:In the present study, we aimed to investigate the underlying reasons and clinical characteristics of cases, in which anthracosis-anthracofibrosis was detected via bronchoscopy.Methods: The study comprised of 109 patients, in whom anthracosis -anthracofibrosis was detected by bronchoscopy between 2002 and 2012.
💡
Conclusion & Impact:Such patients should be evaluated and followed-up for various pulmonary diseases including COPD, pneumonia, tuberculosis and malignancy.
🔬Design:Review & Systematic Survey
📍Scope:2002 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Anthracosis is characterized by accumulation of black pigment in the bronchial mucosa. It may cause anthracofibrosis by leading to mucosal destruction and deformity. In the present study, we aimed to investigate the underlying reasons and clinical characteristics of cases, in which anthracosis-anthracofibrosis was detected via bronchoscopy.Methods: The study comprised of 109 patients, in whom anthracosis -anthracofibrosis was detected by bronchoscopy between 2002 and 2012. Underlying reasons and clinical characteristics of the patients were analysed by reviewing medical records. The study was designed as a retrospective cohort study.Results: The present study included 52 males (47.7%) and 57 females (52.3%) with a mean age of 67.8±9.8 years. Of the patients, 66 (60.6%) had exposure to biomass smoke, 38 (34.9%) had a history of smoking and 5 (4.5%) had occupational exposure. In bronchoscopy, 34 patients were shown to have anthracosis and 75 patients had anthracofibrosis. The right upper lobe (76 patients, 69.7%) and the left upper lobe (74 patients, 67.9%) were the most commonly involved sites; cough (58.7%) and dyspnoea (49.5%) were the most common symptoms, followed by chest pain (36.7%). The most common radiological findings were atelectasis (65.1%) and consolidation (55%). Of the patients, 46.8% had chronic obstructive pulmonary disease (COPD), 24.8% had pneumonia, 18.3% had tuberculosis and 10.1% had malignancy. Conclusion: Biomass smoke exposure is the most important risk factor for patients with anthracosis-anthracofibrosis. Such patients should be evaluated and followed-up for various pulmonary diseases including COPD, pneumonia, tuberculosis and malignancy.

🔖

Cite This Article

UÇAR, E. Y., ARAZ, Ö., AKGÜN, M., MERAL, M., SAĞLAM, L., KAYNAR, H., GÖRGÜNER, A. M. (2014). Bronchial Anthracosis - Anthracofibrosis: Potential Causes and Clinical Characteristics. Solunum, Cilt: 16 - Sayı: 1, 17–20. https://ajindex.com/articles/314294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Naeye R L. The pneumoconiosis; coal worker's pneumoconiosis. In: Sal- dana M J, ed. Pathology of pulmonary disease. Philadelphia, PA, USA: J B Lippincott, 1994: 369-85.
  2. Chung MP, Lee KS, Han JG, Kim H, Rhee CH, Han YC, et al. Bronchial steno- sis due to anthracofibrosis. Chest 1998; 113: 344-50. [CrossRef] Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial an- thracofibrosis: presenting features and clinical course. Respir Med 2009; 103: 757-65. [CrossRef] American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-36. [CrossRef] Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000; 78: 1078-92.
  3. Gupta A, Shah A. Bronchial anthracofibrosis: an emerging pulmonary disease due to biomass fuel exposure. Int J Tuberc Lung Dis 2011; 15: 602-12. [CrossRef] Churg A. The uptake of mineral particles by pulmonary epithelial cells. Am J Respir Crit Care Med 1996; 154: 1124-40. [CrossRef] Özbay B, Uzun K, Arslan H, Zehir İ. Functional and radiological impair- ment in women highly exposed to indoor biomass fuels. Respirology 2001; 6: 255-8. [CrossRef] Ekici A, Ekici M, Kurtipek E, Akin A, Arslan M, Kara T, et al. Obstructive airway diseases in women exposed to biomass smoke. Environmental Research 2005; 99: 93-8. [CrossRef] Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramirez-Sarmiento A, Anto JM, Gea J. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 542-6. [CrossRef] Moran-Mendoza O, Perez-Padilla JR, Salazar-Flores M, Vazquez-Alfaro F. Wood smoke-associated lung disease: a clinical, functional, radiological and pathological description. Int J Tuberc Lung Dis 2008; 12: 1092-8.
  4. Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA. Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci 2012; 9: 406-12. [CrossRef] Kurmi OP, Devereux GS, Smith WCS, Semple S, Steiner MFC, Simkhada P, et al. Reduced lung function due to biomass smoke exposure in young adults in rural Nepal. Eur Respir J 2013; 41: 25-30. [CrossRef] Törün T, Güngör G, Özmen İ, Maden E, Bölükbaşı Y, Tahaoğlu K. Bronchial anthracostenosis in patients exposed to biomass smoke. Solunum 2007; 8: 48-51.